GeoVax receives Nasdaq non-compliance notice but regains compliance via warrant amendment

GeoVax Labs, Inc.

Company issued 802,844 shares and warrants in $1.3M private placement at $1.68/unit, triggering Nasdaq Rule 5635(d).
Nasdaq notified GeoVax on June 20, 2024, of failure to obtain prior shareholder approval for >20% issuance below minimum price.
On June 14, 2024, GeoVax amended warrants via Side Letter to require stockholder approval, eliminating deficiency.
Nasdaq determined compliance regained; matter closed; listing of GOVX and GOVXW unaffected.
Warrant exercise now contingent on shareholder approval; no value attributed to warrants in pricing calculation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.